Skip to main content
Top
Published in: International Journal of Hematology 4/2009

01-11-2009 | Case Report

Mikulicz’s disease with severe thrombocytopenia following autologous stem cell transplantation in a multiple myeloma patient

Authors: Chihiro Sakurai, Kazuteru Ohashi, Kyogo Sakaguchi, Tsunekazu Hishima, Noriko Kamata, Hideki Akiyama, Hisashi Sakamaki

Published in: International Journal of Hematology | Issue 4/2009

Login to get access

Abstract

We report the first case of Mikulicz’s disease (MD) occurring 2 years after autologous peripheral blood stem cell transplantation (PBSCT) for multiple myeloma (MM). A 70-year-old man developed bilateral enlargement of parotid and submandibular glands. The patient had previously received 2 courses of autologous PBSCT for IgG-κ type MM, and had been stable for 2 years. This salivary gland enlargement was initially felt to represent a recurrence of MM, since along with gland swelling, IgG was also elevated. However, repeated biopsy of the left submandibular gland revealed chronic sclerosing sialadenitis rather than plasmacytoma. Results of salivary gland scintigraphy, serological testing, and absence of sicca symptoms also supported the diagnosis of MD. Concurrently, the patient developed severe thrombocytopenia (0.8 × 104/μl). Bone marrow biopsy showed abundant megakaryocytes, suggesting enhanced platelet destruction. After high-dose steroid and immunoglobulin therapy, the platelet count gradually returned to normal with complete resolution of the salivary gland enlargement. No apparent signs of MM recurrence were documented during these clinical events.
Literature
1.
go back to reference Horn B, Viele M, Mentzer W, et al. Autoimmune hemolytic anemia in patients with SCID after T cell-depleted BM and PBSC transplantation. Bone Marrow Transplant. 1999;24:1009–13.CrossRefPubMed Horn B, Viele M, Mentzer W, et al. Autoimmune hemolytic anemia in patients with SCID after T cell-depleted BM and PBSC transplantation. Bone Marrow Transplant. 1999;24:1009–13.CrossRefPubMed
2.
go back to reference Loh Y, Oyama Y, Statkute L, et al. Development of a secondary autoimmune disorder after hematopoietic stem cell transplantation for autoimmune diseases: role of conditioning regimen used. Blood. 2007;109:2643–8.CrossRefPubMed Loh Y, Oyama Y, Statkute L, et al. Development of a secondary autoimmune disorder after hematopoietic stem cell transplantation for autoimmune diseases: role of conditioning regimen used. Blood. 2007;109:2643–8.CrossRefPubMed
3.
go back to reference Yamamoto M, Takahashi H, Naishiro Y, et al. Mikulicz’s disease and systemic Ig4-related plasmacytic syndrome. Jpn J Clin Immunol. 2008;31:1–8.CrossRef Yamamoto M, Takahashi H, Naishiro Y, et al. Mikulicz’s disease and systemic Ig4-related plasmacytic syndrome. Jpn J Clin Immunol. 2008;31:1–8.CrossRef
4.
go back to reference Yamamoto M, Harada S, Ohara M, et al. Beneficial effects of steroid therapy for Mikulicz’s disease. Rheumatology. 2005;44:1322–3.CrossRefPubMed Yamamoto M, Harada S, Ohara M, et al. Beneficial effects of steroid therapy for Mikulicz’s disease. Rheumatology. 2005;44:1322–3.CrossRefPubMed
5.
go back to reference Mikulicz J (1892) Über eine eigenartige symmetrische Erkrankung der Tranen und Mundspeicheldrusen. Stuttgart: Beitr Chir Fortsch Gewidmet Theodor Billroth 610–30. Mikulicz J (1892) Über eine eigenartige symmetrische Erkrankung der Tranen und Mundspeicheldrusen. Stuttgart: Beitr Chir Fortsch Gewidmet Theodor Billroth 610–30.
6.
7.
go back to reference Ohara H, Nakazawa T, Sano H, et al. Systemic extrapancreatic lesions associated with autoimmune pancreatitis. Pancreas. 2005;31:232–7.CrossRefPubMed Ohara H, Nakazawa T, Sano H, et al. Systemic extrapancreatic lesions associated with autoimmune pancreatitis. Pancreas. 2005;31:232–7.CrossRefPubMed
8.
go back to reference Murase K, Matsunaga T, Hayashi T, et al. Successful treatment of autoimmune pancreatitis complicated with autoimmune thrombocytopenia and interstitial pneumonia by prednisolone. Intern Med. 2008;47:1033–8.CrossRefPubMed Murase K, Matsunaga T, Hayashi T, et al. Successful treatment of autoimmune pancreatitis complicated with autoimmune thrombocytopenia and interstitial pneumonia by prednisolone. Intern Med. 2008;47:1033–8.CrossRefPubMed
9.
go back to reference Wada H, Yata K, Mikami M, et al. Multiple myeloma complicated by autoimmune hemolytic anemia. Intern Med. 2004;43:595–8.CrossRefPubMed Wada H, Yata K, Mikami M, et al. Multiple myeloma complicated by autoimmune hemolytic anemia. Intern Med. 2004;43:595–8.CrossRefPubMed
10.
go back to reference Terpos E, Angelopoulou MK, Variami E, et al. Sjögren’s syndrome associated with multiple myeloma. Ann Hematol. 2000;79:449–51.CrossRefPubMed Terpos E, Angelopoulou MK, Variami E, et al. Sjögren’s syndrome associated with multiple myeloma. Ann Hematol. 2000;79:449–51.CrossRefPubMed
11.
go back to reference Isshiki I, Okamoto S, Kakimoto T, et al. Recurrence of autoimmune disease after autologous peripheral blood stem cell transplantation for multiple myeloma. Int J Hematol. 2006;84:354–8.CrossRefPubMed Isshiki I, Okamoto S, Kakimoto T, et al. Recurrence of autoimmune disease after autologous peripheral blood stem cell transplantation for multiple myeloma. Int J Hematol. 2006;84:354–8.CrossRefPubMed
12.
go back to reference Sakaguchi S, Sakaguchi N, Asano M, et al. Immunologic self-tolerance maintained by activated T cells expressing IL-2 receptor α-chains (CD25); breakdown of a single mechanism of self-tolerance causes various autoimmune diseases. J Immunol. 1995;155:1151–64.PubMed Sakaguchi S, Sakaguchi N, Asano M, et al. Immunologic self-tolerance maintained by activated T cells expressing IL-2 receptor α-chains (CD25); breakdown of a single mechanism of self-tolerance causes various autoimmune diseases. J Immunol. 1995;155:1151–64.PubMed
13.
go back to reference Ogose T, Watanabe T, Suzuya H, et al. Autoimmune hepatitis following allogeneic PBSCT from an HLA-matched sibling. Bone Marrow Transplant. 2003;31:829–32.CrossRefPubMed Ogose T, Watanabe T, Suzuya H, et al. Autoimmune hepatitis following allogeneic PBSCT from an HLA-matched sibling. Bone Marrow Transplant. 2003;31:829–32.CrossRefPubMed
14.
go back to reference Liu J, Anderson BE, Robert ME, et al. Selective T-cell subset ablation demonstrates a role for T1 and T2 cells in ongoing acute graft-versus-host disease. A model system for the reversal of disease. Blood. 2001;98:3367–75.CrossRefPubMed Liu J, Anderson BE, Robert ME, et al. Selective T-cell subset ablation demonstrates a role for T1 and T2 cells in ongoing acute graft-versus-host disease. A model system for the reversal of disease. Blood. 2001;98:3367–75.CrossRefPubMed
Metadata
Title
Mikulicz’s disease with severe thrombocytopenia following autologous stem cell transplantation in a multiple myeloma patient
Authors
Chihiro Sakurai
Kazuteru Ohashi
Kyogo Sakaguchi
Tsunekazu Hishima
Noriko Kamata
Hideki Akiyama
Hisashi Sakamaki
Publication date
01-11-2009
Publisher
Springer Japan
Published in
International Journal of Hematology / Issue 4/2009
Print ISSN: 0925-5710
Electronic ISSN: 1865-3774
DOI
https://doi.org/10.1007/s12185-009-0428-9

Other articles of this Issue 4/2009

International Journal of Hematology 4/2009 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine